Sig North Trading, Ulc Bausch Health Companies Inc. Transaction History
Sig North Trading, Ulc
- $2.28 Billion
- Q2 2024
A detailed history of Sig North Trading, Ulc transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Sig North Trading, Ulc holds 90,100 shares of BHC stock, worth $749,632. This represents 0.03% of its overall portfolio holdings.
Number of Shares
90,100
Previous 164,700
45.29%
Holding current value
$749,632
Previous $1.75 Million
64.11%
% of portfolio
0.03%
Previous 0.1%
Shares
4 transactions
Others Institutions Holding BHC
# of Institutions
275Shares Held
279MCall Options Held
5.68MPut Options Held
17.4M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$289 Million2.24% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny26.4MShares$220 Million14.13% of portfolio
-
Goldentree Asset Management LP New York, NY22.4MShares$187 Million15.5% of portfolio
-
Nomura Holdings Inc Tokyo, M019.4MShares$161 Million0.27% of portfolio
-
National Bank Of Canada15.7MShares$130 Million0.17% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $3.01B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...